Skip to main navigation Skip to search Skip to main content

LuCa-MERIT-1: First-in-human, open label, Phase I dose confirmation trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer

  • Arulananda, Surein (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

ERM Reference Number: 115838
Monash Health Reference: RES-25-0000-070A
Review Reference: SSA/115838/MonH-2025-486108(v1)

Animal Ethics: Not required; Human Ethics: N/A (Ethics remains through Monash Health as per head agreement); Gene Tech: Not required; Biosafety/Radiation: No; Split Grants: N/A
StatusActive
Effective start/end date12/06/25 → 11/06/30

Clinical Trial Phase

  • Phase I